Compare Walt Disney Co (DIS) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Walt Disney Co vs BIO-TECHNE Corp — how do they compare? Walt Disney Co trades at $95.99 (market cap $166.71B), while BIO-TECHNE Corp trades at $71.23 (market cap $11.12B). The key difference: Walt Disney Co is far larger — about 15× BIO-TECHNE Corp's market cap, and Walt Disney Co pays the higher dividend (1.56%). Which is the better fit depends on your goals.
| DIS | TECH | |
|---|---|---|
Market Cap | $166.71B | $11.12B |
Volume | 7,546,013 | — |
Sector | Media | Health |
52-Week High | $122.94 | $71.38 |
52-Week Low | $92.40 | $43.31 |
Enterprise Value | $208.38B | $11.20B |
Dividend Yield | 1.56% | 0.45% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Disney (DIS) trades at $95.87, up 0.25% with a P/E of 15.36 and strong earnings beats in recent quarters. The company shows robust fundamentals with $94.43B revenue and $12.40B net income in 2025, though technical indicators signal bearish momentum. Recent news highlights advertising opportunities with major events and regulatory challenges with the FCC.
Outlook remains positive with analyst consensus at $125.60 target, representing 31% upside. Key opportunities include sports broadcasting rights and theme park recovery, while risks involve box office performance and regulatory pressures. The stock offers value with improving profitability and strong cash flow generation.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Walt Disney Co
The Walt Disney Company is an entertainment company with operations in media networks, park experiences & consumer products, studio entertainment and Direct-to-Consumer networks and channels. The Company serves customers worldwide.
Read more on DIS →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
